Aileron Therapeutics Inc (ALRN)
3.85
+0.09
(+2.39%)
USD |
NASDAQ |
May 06, 12:12
Aileron Therapeutics Max Drawdown (5Y): 99.06% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.06% |
March 31, 2024 | 99.06% |
February 29, 2024 | 99.06% |
January 31, 2024 | 99.06% |
December 31, 2023 | 99.06% |
November 30, 2023 | 99.06% |
October 31, 2023 | 99.06% |
September 30, 2023 | 99.06% |
August 31, 2023 | 99.06% |
July 31, 2023 | 99.06% |
June 30, 2023 | 99.06% |
May 31, 2023 | 99.06% |
April 30, 2023 | 99.06% |
March 31, 2023 | 99.06% |
February 28, 2023 | 99.06% |
January 31, 2023 | 99.06% |
December 31, 2022 | 99.06% |
November 30, 2022 | 99.06% |
October 31, 2022 | 99.06% |
September 30, 2022 | 99.06% |
August 31, 2022 | 99.06% |
July 31, 2022 | 98.78% |
June 30, 2022 | 98.26% |
May 31, 2022 | 98.05% |
April 30, 2022 | 98.05% |
Date | Value |
---|---|
March 31, 2022 | 98.05% |
February 28, 2022 | 98.05% |
January 31, 2022 | 98.05% |
December 31, 2021 | 98.05% |
November 30, 2021 | 98.05% |
October 31, 2021 | 98.05% |
September 30, 2021 | 98.05% |
August 31, 2021 | 98.05% |
July 31, 2021 | 98.05% |
June 30, 2021 | 98.05% |
May 31, 2021 | 98.05% |
April 30, 2021 | 98.05% |
March 31, 2021 | 98.05% |
February 28, 2021 | 98.05% |
January 31, 2021 | 98.05% |
December 31, 2020 | 98.05% |
November 30, 2020 | 98.05% |
October 31, 2020 | 98.05% |
September 30, 2020 | 98.05% |
August 31, 2020 | 98.05% |
July 31, 2020 | 98.05% |
June 30, 2020 | 98.05% |
May 31, 2020 | 98.05% |
April 30, 2020 | 98.05% |
March 31, 2020 | 98.05% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
95.24%
Minimum
May 2019
99.06%
Maximum
Aug 2022
98.19%
Average
98.05%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
EyePoint Pharmaceuticals Inc | 93.95% |
INVO Bioscience Inc | 99.83% |
Bio-Path Holdings Inc | 99.48% |
SINTX Technologies Inc | 100.00% |
NovaBay Pharmaceuticals Inc | 99.91% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -61.19 |
Beta (5Y) | 2.321 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 118.8% |
Historical Sharpe Ratio (5Y) | -0.2973 |
Historical Sortino (5Y) | -0.7291 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 42.87% |